G-BA decisions from 20 April 2023
Here are the G-BA decisions from the G-BA meeting held on 20 April 2023 on the early benefit assessments of Ultomiris, Genvoya,
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Here are the G-BA decisions from the G-BA meeting held on 20 April 2023 on the early benefit assessments of Ultomiris, Genvoya,